ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,182.96
-0.85%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,426.795
0.19%
Brent Oil
84.09
-0.30%
Bitcoin
64,646.34
-0.32%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Silo Pharma Inc (SILO)

  7. Silo Pharma Inc (SILO) News

Silo Pharma (SILO)

Silo Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SILO
DateTimeSourceHeadlineSymbolCompany
21/06/202314:00GlobeNewswire Inc.Silo Pharma’s SPU-21 Treatment for Autoimmune Disease Awarded U.S. PatentNASDAQ:SILOSilo Pharma Inc
13/06/202313:05GlobeNewswire Inc.Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant TherapeuticNASDAQ:SILOSilo Pharma Inc
02/06/202313:50GlobeNewswire Inc.Silo Pharma Announces Participation on Webull Corporate Communications Service PlatformNASDAQ:SILOSilo Pharma Inc
30/05/202314:00GlobeNewswire Inc.Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21NASDAQ:SILOSilo Pharma Inc
26/05/202321:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SILOSilo Pharma Inc
18/05/202321:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SILOSilo Pharma Inc
09/05/202313:05GlobeNewswire Inc.Silo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s DiseaseNASDAQ:SILOSilo Pharma Inc
24/04/202313:15GlobeNewswire Inc.Silo Pharma to Present at Psychedelic Drug Development ConferenceNASDAQ:SILOSilo Pharma Inc
19/04/202314:00GlobeNewswire Inc.Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related DisordersNASDAQ:SILOSilo Pharma Inc
27/03/202314:00GlobeNewswire Inc.Silo Pharma Announces filing of Patent for Treatment of FibromyalgiaNASDAQ:SILOSilo Pharma Inc
15/03/202312:40GlobeNewswire Inc.Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for FibromyalgiaNASDAQ:SILOSilo Pharma Inc
15/02/202321:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SILOSilo Pharma Inc
14/02/202321:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SILOSilo Pharma Inc
13/02/202313:35GlobeNewswire Inc.Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’sNASDAQ:SILOSilo Pharma Inc
03/02/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SILOSilo Pharma Inc
02/02/202313:50GlobeNewswire Inc.Silo Pharma Announces Expansion of Intellectual Property PortfolioNASDAQ:SILOSilo Pharma Inc
31/01/202321:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SILOSilo Pharma Inc
31/01/202312:45GlobeNewswire Inc.Silo Pharma Announces Stock Repurchase ProgramNASDAQ:SILOSilo Pharma Inc
20/01/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SILOSilo Pharma Inc
10/01/202315:15GlobeNewswire Inc.Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on InflammationNASDAQ:SILOSilo Pharma Inc
30/12/202213:10GlobeNewswire Inc.Silo Pharma Announces Positive Study Results of SPU- 21 for ArthritisNASDAQ:SILOSilo Pharma Inc
15/12/202221:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SILOSilo Pharma Inc
01/12/202221:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SILOSilo Pharma Inc
01/12/202214:00GlobeNewswire Inc.Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic MedicineNASDAQ:SILOSilo Pharma Inc
21/11/202212:45GlobeNewswire Inc.Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human TissueNASDAQ:SILOSilo Pharma Inc
11/11/202213:15GlobeNewswire Inc.Silo Pharma Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine FormulationNASDAQ:SILOSilo Pharma Inc
10/11/202221:49Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SILOSilo Pharma Inc
26/10/202214:00GlobeNewswire Inc.Silo Pharma to Discuss Mainstream Pharma and Psychedelics at Wonderland Miami ConferenceNASDAQ:SILOSilo Pharma Inc
20/10/202213:05GlobeNewswire Inc.Silo Pharma Announces Data Supporting Therapeutic Potential of SPC-14 for Alzheimer’s Disease in Pre-Clinical StudyNASDAQ:SILOSilo Pharma Inc
18/10/202222:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SILOSilo Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:SILO

Your Recent History

LSE
LWI
Lowland Investment
BIT
P24A55
NLBNPIT24A55 20241218 18...
BIT
P24LV6
NLBNPIT24LV6 20250620 22
BIT
P22SH4
NLBNPIT22SH4 20240920 800
BIT
P1UEF0
NLBNPIT1UEF0 20351221 78...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved